Meilleure Health International Industry Group Limited logo

Meilleure Health International Industry Group Limited

2327.HK

HKSEIndustrialsConglomerates

Latest quote

HK$0.242

+HK$0.002 · +0.83%

Aug 21, 6:09 PM HKT

2327.HK company overview

Historical prices · Market data may be delayed.

Company profile

Company website

Meilleure Health International Industry Group Limited functions as an investment holding company, overseeing a broad spectrum of ventures in Hong Kong, the People's Republic of China, and other international markets. Its diverse operations include industrial hemp, healthcare-related services, trading, various agency services, and both property investment/leasing and development. The company actively engages in the commerce of construction supplies, the creation and sale of residential real estate, property asset management, and the distribution of health-related goods. Furthermore, it provides real estate brokerage, services focused on the application of cannabidiol (CBD) derivatives, and comprehensive health management offerings, such as anti-aging treatments, aesthetic medicine, and general wellness consulting. It also acts as an agent for healthcare product sales. Formerly known as U-Home Group Holdings Limited, the company rebranded to Meilleure Health International Industry Group Limited in March 2017. Its primary corporate office is located in Admiralty, Hong Kong.

Industry
Conglomerates
Sector
Industrials
Headquarters
HK
CEO
Wen Chuan Zhou
Listed since
Oct 14, 2003
Employees
42

Market position

Day range

Current HK$0.242

52-week range

Current HK$0.242

Open
HK$0.239
Previous close
HK$0.24
Volume
60K
0.18× average
Average volume
329.9K
Average daily volume
Market cap
981.4M HKD
Beta
0.03
Market reference 1
50-day average
HK$0.2491
-2.84% below average
200-day average
HK$0.2648
-8.61% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
1.44B HKD
P/E (TTM)
26.02×
P/B (TTM)
0.79×
P/S (TTM)
26.87×
EV / EBITDA
-160.81×
Earnings yield
3.51%
Free cash flow yield
-4.68%
Dividend yield
1.65%

Profitability & efficiency

Gross margin
61.97%
Operating margin
-26.59%
Net margin
104.01%
Return on equity
3.04%
Return on assets
2.09%
Return on invested capital
-0.43%

Financial health

Debt / equity
0.31×
Current ratio
2.81×
Altman Z-score
1.78
Piotroski F-score
5 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends117%65%13%-40%Gross margin, FY2021: 39.89%Gross margin, FY2022: 55.68%Gross margin, FY2023: 60.39%Gross margin, FY2024: 57.04%Gross margin, FY2025: 61.97%Operating margin, FY2021: 21.05%Operating margin, FY2022: 26.89%Operating margin, FY2023: 30.44%Operating margin, FY2024: -7.61%Operating margin, FY2025: -26.59%Net margin, FY2021: 23.84%Net margin, FY2022: 14.86%Net margin, FY2023: 31.58%Net margin, FY2024: 64.09%Net margin, FY2025: 104.01%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 39.89%. Gross margin FY2022 55.68%. Gross margin FY2023 60.39%. Gross margin FY2024 57.04%. Gross margin FY2025 61.97%. Operating margin FY2021 21.05%. Operating margin FY2022 26.89%. Operating margin FY2023 30.44%. Operating margin FY2024 -7.61%. Operating margin FY2025 -26.59%. Net margin FY2021 23.84%. Net margin FY2022 14.86%. Net margin FY2023 31.58%. Net margin FY2024 64.09%. Net margin FY2025 104.01%.

Income trends

Revenue

36.52M HKD-27.94%

Operating income

−9.71M HKD-151.97%

Net income

37.98M HKD+16.94%
Income trends across reported periods279.31M HKD174.21M HKD69.11M HKD−35.99M HKDRevenue, FY2021: 253.03M HKDRevenue, FY2022: 119.89M HKDRevenue, FY2023: 129.3M HKDRevenue, FY2024: 50.68M HKDRevenue, FY2025: 36.52M HKDOperating income, FY2021: 53.25M HKDOperating income, FY2022: 32.24M HKDOperating income, FY2023: 39.36M HKDOperating income, FY2024: −3.85M HKDOperating income, FY2025: −9.71M HKDNet income, FY2021: 60.32M HKDNet income, FY2022: 17.82M HKDNet income, FY2023: 40.83M HKDNet income, FY2024: 32.48M HKDNet income, FY2025: 37.98M HKDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 253.03M HKD. Revenue FY2022 119.89M HKD. Revenue FY2023 129.3M HKD. Revenue FY2024 50.68M HKD. Revenue FY2025 36.52M HKD. Operating income FY2021 53.25M HKD. Operating income FY2022 32.24M HKD. Operating income FY2023 39.36M HKD. Operating income FY2024 −3.85M HKD. Operating income FY2025 −9.71M HKD. Net income FY2021 60.32M HKD. Net income FY2022 17.82M HKD. Net income FY2023 40.83M HKD. Net income FY2024 32.48M HKD. Net income FY2025 37.98M HKD.
Metric (HKD)FY2025FY2024FY2023FY2022FY2021
Revenue36.52M HKD50.68M HKD129.3M HKD119.89M HKD253.03M HKD
Cost of goods sold13.89M HKD21.77M HKD51.21M HKD53.13M HKD152.1M HKD
Gross profit22.63M HKD28.91M HKD78.09M HKD66.76M HKD100.93M HKD
Selling, general, and administrative31.17M HKD31.6M HKD39.34M HKD35.69M HKD42.66M HKD
Operating expenses32.34M HKD31.8M HKD55.11M HKD33.08M HKD47.68M HKD
Interest income29.3M HKD22.05M HKD18.82M HKD26.91M HKD12.45M HKD
Interest expense9.29M HKD10.29M HKD11.41M HKD11.45M HKD8.39M HKD
Depreciation and amortization737K HKD1.63M HKD2.64M HKD3.85M HKD3.58M HKD
Operating income−9.71M HKD−3.85M HKD39.36M HKD32.24M HKD53.25M HKD
Net income37.98M HKD32.48M HKD40.83M HKD17.82M HKD60.32M HKD

Company facts updated Aug 24, 2026.

2327.HK peers

Continue in GoAI

Research 2327.HK

research.disclaimer